Viewing Study NCT02662959


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2026-02-27 @ 7:06 PM
Study NCT ID: NCT02662959
Status: UNKNOWN
Last Update Posted: 2016-01-26
First Post: 2015-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan as 3rd Line Therapy in Gastric Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stomach Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemotherapy, metastatic gastric cancer, irinotecan View